The success of Exscalate
Drug discovery projects
Whether collaborating with pioneering biopharma start-ups or working as part of a consortium of partners, Exscalate’s AI-driven supercomputing platform is helping to rapidly identify effective treatments to address unmet clinical needs.
Exscalate is boosting its drug discovery platform through our involvement in a number of European technology projects. Together with partners, these projects are harnessing the unprecedented power of supercomputing resources together with advances in machine learning and simulation to equip the scientific community with the tools that will enable them to find better cures, faster.
We have formed many successful partnerships. Together we are accelerating drug discovery.